Sign in

CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831971007
Phone
650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
  1. ARS Other Annual Report to Security Holders
  2. DEFA14A Proxy Proxy Materials
  3. EFFECT Other Notice of Effectiveness
  4. EFFECT Other Notice of Effectiveness
  5. 144 Insider Sale of Securities
  6. S-8 Other Securities Offered to Employees in Benefit Plans
  7. ARS Other Annual Report to Security Holders
  8. DEFA14A Proxy Proxy Materials
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  14. EFFECT Other Notice of Effectiveness
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. 144 Insider Sale of Securities
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 1 of 8 · 154 filings